Found: 35
Select item for more details and to access through your institution.
Bevacizumab for recurrent hemangioendothelioma.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 7, p. 2389, doi. 10.1245/s10434-020-08219-w
- By:
- Publication type:
- Article
Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome.
- Published in:
- Deutsches Ärzteblatt International, 2008, v. 105, n. 43, p. 6
- By:
- Publication type:
- Article
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 3, p. 268, doi. 10.1007/s00262-005-0021-x
- By:
- Publication type:
- Article
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 6, p. 251, doi. 10.1159/000538143
- By:
- Publication type:
- Article
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 11, p. 628, doi. 10.1159/000510258
- By:
- Publication type:
- Article
Immunotherapy of Colon Cancer.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 5, p. 282, doi. 10.1159/000488918
- By:
- Publication type:
- Article
Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc<sup>+</sup> Monocytes in Rectal Cancer.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00602
- By:
- Publication type:
- Article
Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 715, doi. 10.1111/j.1365-2125.2011.03965.x
- By:
- Publication type:
- Article
Neoadjuvant Therapy in Patients with Pancreatic Cancer: A Disappointing Therapeutic Approach?
- Published in:
- Cancers, 2011, v. 3, n. 2, p. 2286, doi. 10.3390/cancers3022286
- By:
- Publication type:
- Article
Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 12, p. 2142, doi. 10.1002/ijc.34894
- By:
- Publication type:
- Article
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3).
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 8, p. 1341, doi. 10.1002/ijc.33881
- By:
- Publication type:
- Article
Colorectal Liver Metastases: an Update on Palliative Treatment Options.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2012, v. 21, n. 1, p. 83
- By:
- Publication type:
- Article
Carcinoma of Unknown Primary – an Orphan Disease?
- Published in:
- Breast Care, 2008, v. 3, n. 3, p. 164, doi. 10.1159/000136001
- By:
- Publication type:
- Article
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial—PaCa-DD-041 (Eudra-CT 2009-011968-11).
- Published in:
- Strahlentherapie und Onkologie, 2021, v. 197, n. 1, p. 19, doi. 10.1007/s00066-020-01654-4
- By:
- Publication type:
- Article
Feasibility of High Activity Rhenium-188-Microsphere in Hepatic Radioembolization.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 12, p. 942, doi. 10.1093/jjco/hym137
- By:
- Publication type:
- Article
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 59, doi. 10.1016/j.clcc.2022.12.003
- By:
- Publication type:
- Article
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of Application and Intensity of Bevacizumab-based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Successful Combination of Olaparib and <sup>225</sup>Ac-Dotatate in a Patient with Neuroendocrine Tumor G3 and BRCA Mutation.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 1166, doi. 10.1159/000533198
- By:
- Publication type:
- Article
Comparison of histopathological and gene expression-based typing of cancer of unknown primary.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2010, v. 456, n. 1, p. 23, doi. 10.1007/s00428-009-0867-y
- By:
- Publication type:
- Article
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.
- Published in:
- Frontiers in Genetics, 2022, v. 12, p. 1, doi. 10.3389/fgene.2021.811291
- By:
- Publication type:
- Article
The Role of New Agents in the Treatment of Colorectal Cancer.
- Published in:
- Oncology, 2004, v. 66, n. 1, p. 1, doi. 10.1159/000076329
- By:
- Publication type:
- Article
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e414, doi. 10.1002/onco.13623
- By:
- Publication type:
- Article
Chemotherapy in Elderly Patients with Colorectal Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 390, doi. 10.1634/theoncologist.2007-0043
- By:
- Publication type:
- Article
Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-521
- By:
- Publication type:
- Article
Dose escalating study of cetuximab and 5-FU/ folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 521, doi. 10.1186/1471-2407-14-521
- By:
- Publication type:
- Article
Concomitant metastatic head-and-neck cancer and pancreatic cancer assessed by αvβ6-integrin PET/CT using <sup>68</sup>Ga-Trivehexin: incidental detection of a brain metastasis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 11, p. 3469, doi. 10.1007/s00259-024-06750-6
- By:
- Publication type:
- Article
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients - an observational study.
- Published in:
- Experimental & Translational Stroke Medicine, 2013, v. 5, n. 1, p. 1, doi. 10.1186/2040-7378-5-7
- By:
- Publication type:
- Article
Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Patients' perspectives on palliative chemotherapy of colorectal and non - colorectal cancer: a prospective study in a chemotherapy- experienced population.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-66
- By:
- Publication type:
- Article
Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced population.
- Published in:
- 2013
- By:
- Publication type:
- journal article